Kirkland among US firms acting on $90bn pharma merger

Kirkland & Ellis, Sullivan & Cromwell and Arnold & Porter Kaye Scholer are the firms involved in the latest deal between US pharmaceutical giants, Bristol-Myers Squibb, Celgene and Amgen, valued at $13.4bn. The deal is related to the $90bn merger between the Bristol-Myers Squibb and Celgene, announced in January, and the sale of Celgene’s skin […]

drugs pharma laboratory

Kirkland and Wachtell join Irish duo on pharma mega-deal

Kirkland & Ellis and Wachtell Lipton Rosen & Katz were the two lead US advisers on the $63bn transatlantic deal between pharmaceutical giants AbbVie and Allergan. AbbVie, an American biopharmaceutical company, has acquired Allergan, a Dublin-based botox-maker, in a cash and stock deal. The combined company is expected to increase leadership across healthcare fields such […]